Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain

AIDS Reader

Volumn 11, Issue 11, 2001, Pages 577-580

  Bundow, D ^a   Rosoff, L ^a   Aboulafia, D M ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

Author keywords

Adverse drug reaction; Hepatotoxicity; HIV; Nevirapine; Nonnucleoside reverse transcriptase inhibitor

Indexed keywords

ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; ZIDOVUDINE;

ADULT; ANOREXIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; EOSINOPHILIA; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; MALE; NAUSEA; PATHOPHYSIOLOGY; RASH; SYMPTOM; TOXIC HEPATITIS;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DRUG HYPERSENSITIVITY; HEPATITIS, TOXIC; HIV INFECTIONS; HUMANS; JAUNDICE; MALE; NEVIRAPINE; REVERSE TRANSCRIPTASE INHIBITORS;

EID: 0035207009     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
2. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers
3. High-dose nevirapine: Safety, pharmacokinetics, and antiviral effects in patients with human immunodeficiency virus infection
4. A randomized double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients
5. Efavirenz associated with corticosteroids in patients with previous severe hypersensitivity reactions due to nevirapine
6. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy
7. Cutaneous, hepatic and hematologic manifestations due to nevirapine: DRESS syndrome?
8. Severe hepatic failure related to nevirapine treatment
9. Nevirapine-induced cutaneous hypersensitivity reactions and successful tolerance induction
10. Risks and benefits of replacing protease inhibitors by nevirapine in HIV-infected subjects under long-term successful triple combination therapy
11. Nevirapine-induced hepatitis treated with corticosteroids?
12. Initial observations on the efficacy of highly active antiretroviral therapy in the treatment of HIV-associated autoimmune thrombocytopenia
13. Important drug warning
14. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis in 2 health care workers
15. Nevirapine and postexposure prophylaxis for human immunodeficiency virus
16. Nevirapine-induced hepatitis: A case series and review of the literature